ChatGPT SearchJun 25, 2026
Mursla Bio uses AI and blood-based multi-omics diagnostics to stratify patients and identify biomarkers that can guide therapy selection
Loading…
Mursla Bio is a biotechnology company that develops liquid biopsy diagnostic tests based on its proprietary tissue-specific extracellular vesicles platform. Its primary product, EvoLiver, is designed to conduct early-stage liver cancer surveillance in patients with advanced liver cirrhosis. The company serves the medical and diagnostic sectors by providing non-invasive, multiomic insights from blood samples.
AI named Mursla Bio in June 2026.
Question: Which startups help doctors use patient-specific diagnostics to choose treatments earlier?
ChatGPT SearchJun 25, 2026
Mursla Bio uses AI and blood-based multi-omics diagnostics to stratify patients and identify biomarkers that can guide therapy selection
AI cited mursla.com in these answers, after aitiologic.com, avenir.tech, and cureradar.com.
mursla.com 9%Other sites 91%
Excerpts where Mursla Bio appeared in the AI's answer
Mursla Bio uses AI and blood-based multi-omics diagnostics to stratify patients and identify biomarkers that can guide therapy selection
